Genetic risk scores may compound rather than solve the issue of prostate cancer overdiagnosis. Horton RH, Dunlop MG, Houlston RS, Lucassen A, et al. Br J Cancer 2022 Nov 28. doi: 10.1038/s41416-022-02080.

Read + Share

Amedeo Smart

Independent Medical Education

Horton RH, Dunlop MG, Houlston RS, Lucassen A, et al. Genetic risk scores may compound rather than solve the issue of prostate cancer overdiagnosis. Br J Cancer 2022 Nov 28. doi: 10.1038/s41416-022-02080.
PMID: 36443602